-
Product Insights
NewZika Virus Infections – Drugs In Development, 2024
Empower your strategies with our Zika Virus Infections – Drugs In Development, 2024 report and make more profitable business decisions. Zika virus infection is caused by a virus transmitted primarily by Aedes mosquitoes. Zika virus is a member of the Flaviviridae family. Symptoms include fever, skin rashes, conjunctivitis, muscle and joint pain, malaise, and headache. Risk factors include being in tropical and subtropical areas. Zika virus can also be transmitted through sexual intercourse. Treatment is aimed at relieving symptoms (joint pain...
-
Product Insights
NewTrypanosomiasis – Drugs In Development, 2024
Empower your strategies with our Trypanosomiasis – Drugs In Development, 2024 report and make more profitable business decisions. Trypanosomiasis, also known as sleeping sickness in humans and nagana in animals, is a parasitic disease caused by protozoan parasites of the genus Trypanosoma. There are two main forms of the disease, each caused by different species of Trypanosoma. African trypanosomiasis (sleeping sickness) is transmitted by tsetse flies and is predominantly found in sub-Saharan Africa. It is caused by two subspecies of the...
-
Product Insights
NewGap Junction Beta 2 Protein – Drugs In Development, 2024
The Gap Junction Beta 2 Protein pipeline drugs market research report outlays comprehensive information on the Gap Junction Beta 2 Protein targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Ear Nose Throat Disorders which include indications of Hearing Disorders, and Presbycusis. It also reviews key players involved in Gap Junction Beta 2 Protein targeted therapeutics development with...
-
Product Insights
NewType 2 Angiotensin II Receptor – Drugs In Development, 2024
The Type 2 Angiotensin II Receptor pipeline drugs market research report outlays comprehensive information on the Type 2 Angiotensin II Receptor targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Central Nervous System, Respiratory, Cardiovascular, and Dermatology which include indications of Neuropathic Pain (Neuralgia), Inflammatory Pain, Unspecified Respiratory Disorders, Idiopathic Pulmonary Fibrosis, Hypertension, Pulmonary Arterial Hypertension, Wounds, and...
-
Product Insights
NewBacillary Dysentery (Shigellosis) – Drugs In Development, 2024
Empower your strategies with our Bacillary Dysentery (Shigellosis) – Drugs In Development, 2024 report and make more profitable business decisions. Shigella infection (shigellosis) is an intestinal disease caused by bacteria known as shigella. Symptoms include diarrhea, abdominal cramps, and fever. Predisposing factors include eating contaminated food, age, international travel, and being a homosexual man. Treatment includes antibiotics. The Bacillary Dysentery (Shigellosis) drugs in development market research report provide comprehensive information on the therapeutics under development for Bacillary Dysentery (Shigellosis), complete with...
-
Product Insights
NewUsher Syndrome – Drugs In Development, 2024
Empower your strategies with our Usher Syndrome – Drugs In Development, 2024 report and make more profitable business decisions. Usher syndrome is an inherited condition characterized by hearing impairment and progressive vision loss. The major symptoms of Usher syndrome are hearing loss and an eye disorder called retinitis pigmentosa. Risk factors include retinal degeneration; prolonged, unprotected exposure to sunlight may accelerate vision loss. Treatment includes cochlear implants, hearing aids, and Vitamin A supplementation. The Usher Syndrome drugs in development market research...
-
Product Insights
NewAnaphylaxis – Drugs In Development, 2024
Empower your strategies with our Anaphylaxis – Drugs In Development, 2024 report and make more profitable business decisions. Anaphylaxis is a severe, potentially life-threatening allergic reaction. Anaphylaxis symptoms include dizziness, nausea, vomiting or diarrhea, feeling of warmth, constriction of the airways, and a swollen tongue or throat. Risk factors include personal history of anaphylaxis, allergies or asthma, and family history. Treatment includes beta-agonists, antihistamines, and cortisone. The Anaphylaxis drugs in development market research report provide comprehensive information on the therapeutics under...
-
Product Insights
NewTyphoid Fever – Drugs In Development, 2024
Empower your strategies with our Typhoid Fever – Drugs In Development, 2024 report and make more profitable business decisions. Typhoid fever is an infection that causes diarrhea and a rash. It is most commonly due to a type of bacterium called Salmonella typhi. Symptoms include abdominal tenderness, agitation, chills, delirium, hallucinations, severe fatigue, and weakness. Treatment includes antibiotics and supportive therapy. The Typhoid Fever drugs in development market research report provide comprehensive information on the therapeutics under development for Typhoid Fever,...
-
Product Insights
NewPlague – Drugs In Development, 2024
Empower your strategies with our Plague – Drugs In Development, 2024 report and make more profitable business decisions. Plague is an infection caused by the bacterium Yersinia pestis. The organism is transmitted to humans who are bitten by fleas that have fed on infected rodents, or when human handle infected animals. Symptoms include headache, fatigue or malaise, muscle aches, fever and chills, abdominal pain, diarrhea and vomiting, shock, and bleeding from the mouth, nose, ectum, or under the skin. Treatment includes...
-
Product Insights
NewChikungunya Fever – Drugs In Development, 2024
Empower your strategies with our Chikungunya Fever – Drugs In Development, 2024 report and make more profitable business decisions. Chikungunya is a viral disease transmitted to humans by the bite of infected Aedes aegypti mosquitoes. Chikungunya virus (CHIKV) is a member of the genus Alpha virus, in the family Togaviridae. Symptoms of Chikungunya includes debilitating arthralgia (joint pain), swelling of joints, stiffness of joints, myalgia (muscular pain), headache, fatigue (weakness), nausea, vomiting, and rash and fever. Treatment includes use of non-steroidal...